Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Antiplatelet Therapy and Cardiovascular Diseases”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | European Heart Journal - Cardiovascular Pharmacotherapy Oxford University Press · United Kingdom Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (17%) | 98% | 75.2 | #4,026 | 455 | 74% | Not recorded | |
| 2 | Aterotromboz = Atherothrombosis · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (17%) | 100% | 24.2 | #47,839 | 58 | 100% | Not recorded | |
| 3 | American Journal of Cardiovascular Drugs Adis, Springer Healthcare · Switzerland Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (12%) | 71% | 73.3 | #4,969 | 321 | 36% | Not recorded | |
| 4 | Platelets Informa · United Kingdom · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (11%) | 62% | 75.2 | #4,018 | 389 | 72% | 4,595 AUD | |
| 5 | Current Vascular Pharmacology Bentham Science Publishers · The Netherlands Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (11%) | 63% | 68.1 | #7,893 | 251 | 9% | Not recorded | |
| 6 | Cardiology and Therapy Adis, Springer Healthcare · United Kingdom · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (11%) | 61% | 68.3 | #7,774 | 231 | 100% | 5,950 EUR | |
| 7 | Journal of Thrombosis and Thrombolysis Springer Science+Business Media · The Netherlands Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (10%) | 57% | 71.8 | #5,804 | 877 | 43% | Not recorded | |
| 8 | Cardiovascular Therapeutics Wiley · United Kingdom · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (10%) | 55% | 67.4 | #8,337 | 241 | 100% | US$2,380 | |
| 9 | Cardiovascular & Haematological Disorders - Drug Targets Bentham Science Publishers · The Netherlands Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (10%) | 57% | 58.3 | #14,020 | 177 | 5% | Not recorded | |
| 10 | Seminars in Thrombosis and Hemostasis Thieme Medical Publishers (Germany) · United States Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (8%) | 44% | 79.9 | #2,198 | 659 | 37% | Not recorded | |
| 11 | Cardiovascular & Hematological Agents in Medicinal Chemistry Bentham Science Publishers · The Netherlands Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (10%) | 55% | 59.3 | #13,301 | 140 | 8% | Not recorded | |
| 12 | Circulation Cardiovascular Interventions Lippincott Williams & Wilkins · United States Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (7%) | 40% | 80.0 | #2,155 | 754 | 57% | Not recorded | |
| 13 | Clinical Pharmacology Advances and Applications Dove Medical Press · New Zealand · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (9%) | 51% | 59.3 | #13,344 | 77 | 100% | US$3,565 | |
| 14 | Journal of Cardiovascular Pharmacology Lippincott Williams & Wilkins · United States Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (7%) | 43% | 74.5 | #4,355 | 809 | 22% | Not recorded | |
| 15 | Medical Research Journal Via Medica · Poland · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (9%) | 55% | 44.1 | #24,315 | 297 | 100% | Not recorded | |
| 16 | Hämostaseologie Thieme Medical Publishers (Germany) · Germany Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (8%) | 45% | 60.0 | #12,915 | 1,084 | 31% | Not recorded | |
| 17 | TH Open Thieme Medical Publishers (Germany) · Germany · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (8%) | 45% | 59.0 | #13,542 | 255 | 100% | 2,875 EUR | |
| 18 | CardioVasc Springer Science+Business Media · Germany Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (11%) | 61% | 28.4 | #42,412 | 960 | 4% | Not recorded | |
| 19 | Chonnam Medical Journal Chonnam National University Medical School · South Korea Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (7%) | 40% | 63.6 | #10,676 | 183 | 100% | Not recorded | |
| 20 | Journal of Cardiovascular Pharmacology and Therapeutics SAGE Publishing · United States · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (7%) | 39% | 62.8 | #11,120 | 142 | 81% | US$1,325 | |
| 21 | Journal of Cardiovascular Intervention Korean Society of Interventional Cardiology · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (9%) | 51% | 40.3 | #28,025 | 112 | 100% | Not recorded | |
| 22 | The Pharmacogenomics Journal Springer Nature · United Kingdom Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (4%) | 22% | 72.5 | #5,405 | 188 | 47% | Not recorded | |
| 23 | Pharmacogenetics and Pharmacogenomics Izdatelstvo OKI · Russia · DOAJ Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (7%) | 43% | 31.4 | #38,645 | 103 | 100% | 30,000 RUB | |
| 24 | Jurnal Klinik dan Riset Kesehatan Indonesia Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (9%) | 50% | 15.8 | #56,757 | 123 | 100% | Not recorded | |
| 25 | Pharmacogenomics Future Medicine · United Kingdom Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (3%) | 17% | 70.4 | #6,561 | 438 | 44% | Not recorded | |
| 26 | Pharmacogenetics and Genomics Lippincott Williams & Wilkins · United Kingdom Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (3%) | 15% | 66.2 | #9,110 | 163 | 33% | Not recorded | |
| 27 | EMJ Interventional Cardiology United Kingdom Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (6%) | 37% | 20.8 | #51,712 | 68 | 100% | Not recorded | |
| 28 | Pakistan Journal of Cardiovascular Intervention Pakistan Publishes on: Antiplatelet Therapy and Cardiovascular Diseases (5%) | 26% | 7.9 | #61,245 | 75 | 100% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.